Form 4: Morgan Stanley CRO Sells $1.55M in Shares

Morgan Stanley's Chief Risk Officer, Charles A. Smith, reported the sale of 8,500 shares of common stock for approximately $1.55 million.

Summary

• Charles A. Smith, Chief Risk Officer of Morgan Stanley (MS), reported a sale of common stock.
• The transaction involved the disposition of 8,500 shares of Morgan Stanley common stock.
• The shares were sold on January 20, 2026, at a weighted average price of $182.0807 per share.
• The total value of the shares sold is approximately $1,547,685.95.
• The sale was executed pursuant to a Rule 10b5-1(c) plan.
• Following the transaction, Charles A. Smith directly beneficially owns 119,127.619 shares of common stock.
• Additionally, 5,494.73 shares are indirectly owned through a 401(k) Plan.

Sentiment

Score: 5

Explanation: A routine insider stock sale under a 10b5-1 plan is generally considered neutral. It reflects personal financial planning rather than a direct statement on company performance or outlook.

Positives

• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale not based on immediate insider information.

Negatives

• No specific negatives are indicated by a routine insider sale.

Risks

• No specific risks are mentioned.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Morgan Stanley's future outlook.

Industry Context

Insider transactions, such as the sale reported by Morgan Stanley's Chief Risk Officer, are common occurrences in the financial industry. These routine disclosures provide transparency into executive stock ownership changes and are often pre-scheduled through 10b5-1 plans to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders: Provides transparency regarding executive stock ownership changes, which is a standard disclosure. The sale is relatively small compared to the company's total market capitalization and the executive's remaining holdings, suggesting minimal impact.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The filing does not mention any specific future actions, events, or milestones.

Key Dates

Keywords

Morgan Stanley, MS, Charles A. Smith, Chief Risk Officer, Insider Sale, Form 4, Stock Transaction, Equity Disposition, 10b5-1 Plan